; 0, noninvasive; 1, invasion into the stroma; 2, invasion into the fat; and 3, invasion into nearby tissue or organs. Note that the study sample size was small and the results were not adjusted for any confounding variables.
People's Hospital, Yuyao, China, located in the Chinese textile asbestos industrial area, where most patients are exposed to asbestos. We reviewed a total of 92 MMs: 34 in the pleura, 56 in the peritoneum, and 2 in the tunica vaginalis.
Asbestos exposure was determined by a trained oncologist (W.M., Z. Guo, or Z. Gao) who interviewed patients for occupational and family histories. Individuals who worked in trades in which asbestos exposure was likely or who grew up or lived in families in which others were employed in the textile industry or trades associated with asbestos were identified as being exposed to asbestos. This retrospective study was approved by the Zhejiang Cancer Hospital Ethical Committee and the Zhejiang Academy of Medical Sciences Ethical Committee. We obtained formalin-fixed, paraffin-embedded tissues from blocks kept in Department of Pathology, Zhejiang Cancer Hospital, and Yuyao Hospital. Patient information was obtained through medical records and patient and family interview. All patients provided verbal informed consent, and data were not deidentified.
Results | Reviewing histologic findings with the aid of a large immunohistochemical panel, we confirmed the diagnosis of MM in 28 patients from ZJCH and 24 from Yuyao People's Hospital (52 of 92 cases [57%]). The male to female ratio was approximately 1:4 (19%; 95% CI, 10%-32%) compared with 4:1 (80%) in the United States (z = 11.0, P < .001). The pleural to peritoneal MM ratio was approximately 1:3 (24%; 95% CI, 13%-38%) compared with 5:1 (83%) in the United States (z = 11.2, P < .001). The mean (SD) age at diagnosis was 50.6 (7.9) years (95% CI, 48.4-52.7 years) compared with 72 (9.5) years in the United States (t 51 = 19.3, P < .001). Twenty of the 52 MMs (5 in the pleura, 14 in the peritoneum, and 1 in the tunica vaginalis) occurred in asbestos-exposed individuals (38%; 95% CI, 25%-53%): 2 of 28 (7%; 95% CI, 1%-23%) at the ZJCH and 18 of 24 (75%; 95% CI, 53%-90%) at Yuyao People's Hospital. Computed tomograms available for 16 of 28 MMs found at the ZJCH supported asbestos exposure in 2 of 16 cases (13%; 95% CI, 2%-38%). Asbestosrelated MMs occurred in 19 women and 1 man. Nine of 52 MMs (17%; 95% CI, 8%-30%) occurred in individuals 40 years or younger compared with less than 1% in the same age group in the United States 3 ( Table 1 and Table 2 ).
Discussion | The higher prevalence of peritoneal vs pleural MMs in China, especially among nonexposed young women, is unique.
3,4,6 Initially we thought that asbestos was the main cause because 13 of 18 peritoneal MMs (72%; 95% CI, 46%-90%) from Yuyao People's Hospital occurred in women exposed to asbestos. However, only 1 of 14 peritoneal MMs (7%; 95% CI, 0%-34%) from the ZJCH was associated with asbestos. Except for asbestos exposure, no significant demographic differences were observed between the ZJCH and Yuyao People's Hospital (Table 1 and Table 2 ), suggesting that asbestos may not be the main cause of MM in these women. These findings point to a unique opportunity to investigate other causes of peritoneal MMs in this population, aside from asbestos. In the United States and Europe, an increasing number of peritoneal MMs do not seem to be associated with asbestos, 5 leading some authors to speculate that a subgroup of peritoneal MMs may have a different pathogenesis. 3, 6 In most industrialized countries, pleural MMs characteristically occur in a setting of asbestos exposure. 3, 6 Because men are most often involved in asbestos trades, the incidence of pleural MMs is higher in men, with a male to female ratio of approximately 4:1. 3, 6 Instead, among Chinese patients with 12
pleural MMs, 10 of 12 were women (83%; 95% CI, 52%-99%) and only 5 of 12 (42%; 95% CI, 15%-72%) had been exposed to asbestos, underscoring the unusual prevalence of MM in Chinese women (Table 1) . 
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Finally, contrary to popular belief, the latest research 4 has
shown that the linear no-threshold model, historically used to estimate cancer risk from exposure to low-dose radiation, is not an accurate measuring tool. Researchers now have found that small doses of radiation may not actually be harmful and certainly do not outweigh the benefits of appropriate medical imaging.
To image or not to image? Today, we are better informed than ever to make the right decision for our patients.
